Protagen AG today announced that it has entered into a long-term collaboration agreement with QIAGEN targeting the development of novel protein-based companion diagnostics for autoimmune disorders. Under the terms of the agreement, QIAGEN will gain access to the proprietary SeroTag® technology platform of Protagen, which enables the discovery and validation of novel protein-based marker panels. […]

SOUTH SAN FRANCISCO, Calif. – Sequenta, Inc., a biotechnology company developing clinical diagnostics based on immune cell receptor genes, today announced that the company has entered into an agreement with Illumina, Inc. (NASDAQ: ILMN). The purpose of the agreement is to commercialize an in vitro diagnostic (IVD) kit that will enable clinical laboratories to utilize […]

Singapore -– Vela Diagnostics announced today that it has completed the listing of its Next-Generation Sequencing (NGS) system with the U.S. Food and Drug Administration (FDA) for clinical use as a class II device. The Vela Diagnostics NGS System comprises the Sentosa® ST401 instruments which provide an automated solution for template preparation and enrichments, the […]

Coralville, IA — Integrated DNA Technologies (IDT) has acquired a license from ELITech Group (Bothell, WA) to manufacture and supply MGB Eclipse® Probes for use as a component in human in vitro diagnostic tests. As a result of improved knowledge and understanding of the human genome, quantitative real-time PCR (qPCR) has become an increasingly important […]

Cleveland, OH -– GenomOncology announced today that the Ohio State University, College of Medicine, Department Of Pathology will use the company’s GO Clinical WorkbenchTM to enable clinical reporting of mutations detected from next generation sequencing (NGS). “Cancer is a complex disease, with tremendous diversity in pathology and genetics,” commented Weiqiang John Zhao, MD, PhD, FCAP, […]

CORALVILLE, IA -– Integrated DNA Technologies (IDT) has acquired a license from ELITech Group (Bothell, WA) to manufacture and supply MGB Eclipse® Probes for use as a component in human in vitro diagnostic tests. As a result of improved knowledge and understanding of the human genome, quantitative real-time PCR (qPCR) has become an increasingly important […]

Boston, MA and Leuven, Belgium -– Cartagenia, leader in providing genetic labs and clinicians with software-based workflow support for variant assessment, lab reporting, and access of relevant knowledge-bases, today announced a partnership with CollabRx that will provide Cartagenia’s customers access to CollabRx’s industry-leading treatment information resources and services. The partnership provides clinical and pathology laboratories […]

Boston, MA and Leuven, Belgium — Cartagenia, leader in providing genetic labs and clinicians with software-based workflow support for variant assessment, lab reporting, and integration of diagnostic knowledge-bases, today announced that it is part of a three-member consortium called Lungcadia that has won a three-year, €1.4 million ($1.76 million) EuroTransBio research grant to develop a […]